Peters JH - Search Results

1

Esophageal stenting for malignant and benign disease: 133 cases on a thoracic surgical service.

Dubecz A, Watson TJ, Raymond DP, Jones CE, Matousek A, Allen J, Salvador R, Polomsky M, Peters JH. Dubecz A, et al. Among authors: peters jh. Ann Thorac Surg. 2011 Dec;92(6):2028-32; discussion 2032-3. doi: 10.1016/j.athoracsur.2011.08.033. Ann Thorac Surg. 2011. PMID: 22115214

2

Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.

Watson TJ, Peters JH. Watson TJ, et al. Among authors: peters jh. Thorac Surg Clin. 2005 Aug;15(3):405-15. doi: 10.1016/j.thorsurg.2005.04.001. Thorac Surg Clin. 2005. PMID: 16104131 Review.

3

Does the value of PET-CT extend beyond pretreatment staging? An analysis of survival in surgical patients with esophageal cancer.

Sepesi B, Raymond DP, Polomsky M, Watson TJ, Litle VR, Jones CE, Hu R, Qiu X, Peters JH. Sepesi B, et al. Among authors: peters jh. J Gastrointest Surg. 2009 Dec;13(12):2121-7. doi: 10.1007/s11605-009-1038-9. Epub 2009 Oct 1. J Gastrointest Surg. 2009. PMID: 19795177

4

Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens.

Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE, Raymond DP, Hu R, Qiu X, Peters JH. Sepesi B, et al. Among authors: peters jh. J Am Coll Surg. 2010 Apr;210(4):418-27. doi: 10.1016/j.jamcollsurg.2010.01.003. J Am Coll Surg. 2010. PMID: 20347733

5

Esophageal perforation: surgical, endoscopic and medical management strategies.

Sepesi B, Raymond DP, Peters JH. Sepesi B, et al. Among authors: peters jh. Curr Opin Gastroenterol. 2010 Jul;26(4):379-83. doi: 10.1097/MOG.0b013e32833ae2d7. Curr Opin Gastroenterol. 2010. PMID: 20473156 Review.

6

Dysphagia postfundoplication: more commonly hiatal outflow resistance than poor esophageal body motility.

Wilshire CL, Niebisch S, Watson TJ, Litle VR, Peyre CG, Jones CE, Peters JH. Wilshire CL, et al. Among authors: peters jh. Surgery. 2012 Oct;152(4):584-92; discussion 592-4. doi: 10.1016/j.surg.2012.07.014. Epub 2012 Aug 31. Surgery. 2012. PMID: 22939748

7

Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.

Lada MJ, Nieman DR, Han M, Timratana P, Alsalahi O, Peyre CG, Jones CE, Watson TJ, Peters JH. Lada MJ, et al. Among authors: peters jh. Surgery. 2013 Oct;154(4):856-64; discussion 864-6. doi: 10.1016/j.surg.2013.07.020. Surgery. 2013. PMID: 24074425

8

Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.

Nieman DR, Peyre CG, Watson TJ, Cao W, Lunt MD, Lada MJ, Han MS, Jones CE, Peters JH. Nieman DR, et al. Among authors: peters jh. Ann Thorac Surg. 2015 Jan;99(1):277-83. doi: 10.1016/j.athoracsur.2014.07.037. Epub 2014 Nov 5. Ann Thorac Surg. 2015. PMID: 25442991

9

Esophageal replacement for end-stage benign esophageal disease.

Watson TJ, DeMeester TR, Kauer WK, Peters JH, Hagen JA. Watson TJ, et al. Among authors: peters jh. J Thorac Cardiovasc Surg. 1998 Jun;115(6):1241-7; discussion 1247-9. doi: 10.1016/S0022-5223(98)70205-3. J Thorac Cardiovasc Surg. 1998. PMID: 9628664 Free article.

10

Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells.

Hu Y, Jones C, Gellersen O, Williams VA, Watson TJ, Peters JH. Hu Y, et al. Among authors: peters jh. Arch Surg. 2007 Jun;142(6):540-4; discussion 544-5. doi: 10.1001/archsurg.142.6.540. Arch Surg. 2007. PMID: 17576890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

577 results

Search Page

Filters